We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 30, 2020

Safety and Efficacy of Sirolimus Plus Endocrine Therapy in Patients With Advanced HR+ Breast Cancer

The Breast

 

Additional Info

Disclosure statements are available on the authors' profiles:

The Breast
Safety and Efficacy of Sirolimus Combined With Endocrine Therapy in Patients With Advanced Hormone Receptor-Positive Breast Cancer and the Exploration of Biomarkers
Breast 2020 Apr 16;52(xx)17-22, Z Yi, B Liu, X Sun, G Rong, W Wang, H Li, X Guan, L Li, J Zhai, C Li, H Qian, F Ma, B Xu

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading